Monogram Technologies Inc
MGRM5.408USD
+0.018+0.33%
Market hours （ET）Quotes delayed by 15 min
191.15MMarket Cap
LossP/E TTM
More Details of Monogram Technologies Inc Company
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Company Info
Ticker SymbolMGRM
Company nameMonogram Technologies Inc
IPO dateMay 18, 2023
CEOMr. Benjamin Sexson
Number of employees27
Security typeOrdinary Share
Fiscal year-endMay 18
Address53 Bridge Street Unit 507
CityBROOKLYN
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code11201
Phone17185763205
Websitehttps://www.monogramtechnologies.com/
Ticker SymbolMGRM
IPO dateMay 18, 2023
CEOMr. Benjamin Sexson
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Benjamin Sexson
Mr. Benjamin Sexson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.01M
--
Mr. Douglas Unis, M.D.
Mr. Douglas Unis, M.D.
Director and founder
Director and founder
3.48M
-1.62%
Mr. Noel Knape, CPA
Mr. Noel Knape, CPA
Chief Financial Officer
Chief Financial Officer
288.79K
+0.11%
Mr. Kamran Shamaei, Ph.D.
Mr. Kamran Shamaei, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.93K
--
Mr. Richard L. (Rick) Van Kirk, Jr.
Mr. Richard L. (Rick) Van Kirk, Jr.
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Ms. Colleen M. Gray
Ms. Colleen M. Gray
Independent Director
Independent Director
--
--
Mr. Paul Riss, CPA
Mr. Paul Riss, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Benjamin Sexson
Mr. Benjamin Sexson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.01M
--
Mr. Douglas Unis, M.D.
Mr. Douglas Unis, M.D.
Director and founder
Director and founder
3.48M
-1.62%
Mr. Noel Knape, CPA
Mr. Noel Knape, CPA
Chief Financial Officer
Chief Financial Officer
288.79K
+0.11%
Mr. Kamran Shamaei, Ph.D.
Mr. Kamran Shamaei, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.93K
--
Mr. Richard L. (Rick) Van Kirk, Jr.
Mr. Richard L. (Rick) Van Kirk, Jr.
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Revenue Breakdown
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jul 17
Updated: Thu, Jul 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Zimmer Biomet Holdings, Inc.
26.98%
Sexson (Benjamin)
11.08%
Unis (Douglas)
9.61%
Icahn School of Medicine at Mount Sinai
6.53%
Pro-Dex Inc
5.06%
Other
40.75%
Shareholders
Shareholders
Proportion
Zimmer Biomet Holdings, Inc.
26.98%
Sexson (Benjamin)
11.08%
Unis (Douglas)
9.61%
Icahn School of Medicine at Mount Sinai
6.53%
Pro-Dex Inc
5.06%
Other
40.75%
Shareholder Types
Shareholders
Proportion
Holding Company
26.98%
Individual Investor
21.50%
Corporation
11.58%
Investment Advisor
3.84%
Investment Advisor/Hedge Fund
1.04%
Research Firm
0.16%
Hedge Fund
0.05%
Other
34.86%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
72
13.80M
38.16%
+158.05K
2025Q1
70
13.80M
38.67%
+170.39K
2024Q4
67
13.51M
39.38%
+322.57K
2024Q3
55
13.06M
41.28%
+264.50K
2024Q2
44
12.27M
38.78%
-449.19K
2024Q1
41
12.14M
38.38%
-162.63K
2023Q4
32
12.30M
41.64%
+1.57M
2023Q3
22
10.73M
36.66%
+319.53K
2023Q2
15
7.55M
25.82%
+7.55M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Sexson (Benjamin)
4.01M
11.23%
--
--
Mar 05, 2025
Unis (Douglas)
3.48M
9.74%
-57.12K
-1.62%
Mar 05, 2025
Icahn School of Medicine at Mount Sinai
2.36M
6.61%
--
--
Mar 05, 2025
Pro-Dex Inc
1.83M
5.12%
--
--
Mar 05, 2025
The Vanguard Group, Inc.
896.70K
2.51%
+241.15K
+36.79%
Mar 31, 2025
Knape (Noel)
288.79K
0.81%
+329.00
+0.11%
Mar 05, 2025
Geode Capital Management, L.L.C.
243.41K
0.68%
+17.03K
+7.52%
Mar 31, 2025
Buckingham Strategic Partners, LLC
213.68K
0.6%
+12.33K
+6.12%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
93.73K
0.26%
-846.00
-0.89%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
iShares Micro-Cap ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
